Additionally, it has already been proved that the overexpression of CCND2 inhibited cell growth of prostate cancer, whereas reduced expression promoted cell proliferation of PCa cells and was correlated with tumour progression to high Gleason score and elevated PSA levels [82]. This evidence concerns the gene CCND2 and prostate carcinoma.